Polyclonal Goat anti-Goat Biotin Antibody (FITC, IF)
Catalog Number: LS-C758060-1
1 mg / $322.00
Antibody: Goat Polyclonal
Applications: Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence
Reactivity: Goat
Format: Liquid
Polyclonal Goat Anti-Mouse IgG1 Secondary Antibody (HRP, IHC, WB)
Secondary AntibodyLSBio Guarantee
| Antibody: | Goat Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Frozen, Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Mouse |
| Format: | Liquid |
$257.00each
Catalog Number: LS-C59107-1
Catalog Number: LS-C59107
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Mouse IgG1 antibody LS-C59107 is an HRP-conjugated goat polyclonal antibody. Validated for ELISA, IHC and WB. Cited in 2 publications.
- Application
- ELISA, IHC-F, IHC-P, WB
- Reactivity
- Ms
- Nonreactive Species
- Hu
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Secondary Antibodies
- Recommended Dilution: ELISA
- 1:4000 - 1:8000
Target
- Target
- Mouse IgG1
- Target Heavy Chain
- IgG1
- Antigen Species
- Ms
- Epitope
- Recognizes Mouse IgG1. Has been cross absorbed against mouse IgM, IgG2a, IgG2b, IgG3 and IgA, pooled human sera and purified human paraproteins. The antibody shows minimal cross-reactivity with human immunoglobulins.
Antibody
- Host Species
- Gt
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Mouse IgG1 paraproteins.
Format
- Conjugate/Label
- HRP
- Format
- Liquid
- Formulation
- PBS, 0.01% Thimerosal, 50% Glycerol
- Volume
- 1 Milliliter
- Preservative
- Yes
- Purification Method
- AP
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease. Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM, Keegan BP, Zhan B, Dumonteil E, Bottazzi ME, Hotez PJ. Human vaccines & immunotherapeutics. 2016 April;12:976-87. PubMed: 26890466 PMC: PMC4962947
